1. Home
  2. ST vs TVTX Comparison

ST vs TVTX Comparison

Compare ST & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensata Technologies Holding plc

ST

Sensata Technologies Holding plc

SELL

Current Price

$42.60

Market Cap

6.3B

Sector

Industrials

ML Signal

SELL

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$51.74

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ST
TVTX
Founded
1916
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.3B
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
ST
TVTX
Price
$42.60
$51.74
Analyst Decision
Buy
Strong Buy
Analyst Count
11
15
Target Price
$53.30
★ $75.21
AVG Volume (30 Days)
1.1M
★ 1.6M
Earning Date
10-27-2026
10-29-2026
Dividend Yield
★ 1.14%
N/A
EPS Growth
N/A
★ 92.89
EPS
★ 1.29
N/A
Revenue
★ $3,704,500,000.00
N/A
Revenue This Year
$4.43
$47.65
Revenue Next Year
$4.23
$49.39
P/E Ratio
$32.56
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$28.16
$22.59
52 Week High
$53.89
$68.73

Technical Indicators

Market Signals
Indicator
ST
TVTX
Relative Strength Index (RSI) 50.26 27.19
Support Level $40.44 $41.75
Resistance Level $43.84 $59.93
Average True Range (ATR) 1.02 2.17
MACD 0.08 -0.78
Stochastic Oscillator 54.24 4.96

Price Performance

Historical Comparison
ST
TVTX

About ST Sensata Technologies Holding plc

Sensata Technologies is a global supplier of sensors and electrical protection for transportation and industrial applications. Sensata sells a bevy of pressure, temperature, force, and position sensors into the automotive, heavy vehicle, industrial, heating, ventilation, and cooling, and aerospace markets. It also sells electrical protection products, like contactors and relays. The majority of the firm's revenue comes from the automotive market, where it focuses on bumper-in applications.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: